Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Operating Leases (2021 - 2025)

iBio (IBIO) has disclosed Operating Leases for 5 consecutive years, with $1.9 million as the latest value for Q4 2025.

  • Quarterly Operating Leases fell 21.14% to $1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Dec 2025, down 21.14% year-over-year, with the annual reading at $2.2 million for FY2025, 18.19% down from the prior year.
  • Operating Leases for Q4 2025 was $1.9 million at iBio, down from $2.1 million in the prior quarter.
  • The five-year high for Operating Leases was $5.5 million in Q1 2022, with the low at $1.9 million in Q4 2025.
  • Average Operating Leases over 5 years is $3.1 million, with a median of $3.0 million recorded in 2023.
  • The sharpest move saw Operating Leases fell 1.01% in 2022, then plummeted 41.87% in 2023.
  • Over 5 years, Operating Leases stood at $5.4 million in 2021, then tumbled by 38.44% to $3.3 million in 2022, then dropped by 12.39% to $2.9 million in 2023, then decreased by 15.87% to $2.4 million in 2024, then dropped by 21.14% to $1.9 million in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $1.9 million, $2.1 million, and $2.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.